Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet-CAPOX) in patients (pts) with locally advanced rectal cancer (LARC)

Liersch, T. and Weiss, C. and Dellas, K. and Hipp, M. and Sauer, R. and Roedel, C. and Arnold, D. (2011) Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet-CAPOX) in patients (pts) with locally advanced rectal cancer (LARC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): e14035. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 30 Apr 2020 06:18
Last Modified: 30 Apr 2020 06:18
URI: https://pred.uni-regensburg.de/id/eprint/20808

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.